BPC-157 30000mcg 0.5mg Capsule In Pakistan
BPC-157 30000mcg 0.5mg Capsule In Pakistan | MyTelestore.com
BPC-157 0.5mg Capsules contain BPC-157, an investigational peptide that has been studied mainly in laboratory and animal research. It has attracted research interest because of proposed effects involving tissue and cellular processes, but human clinical evidence remains limited.
The stated 30,000mcg and 0.5mg specifications should be verified against the original product packaging, because these figures may refer to different product or formulation measurements. 0.5mg equals 500mcg, so the two stated amounts should not automatically be treated as the same active-ingredient quantity.
Product Overview
- Product: BPC-157
- Stated Strength: 0.5mg per capsule
- Additional Stated Amount: 30,000mcg
- Category: Investigational / research peptide
- Form: Capsule
- Availability: Pakistan
What Is BPC-157?
BPC-157 is a synthetic peptide derived from a sequence associated with body-protection compound (BPC) research.
Most research involving BPC-157 has been conducted in preclinical models. Investigations have explored possible biological effects involving tissue repair, gastrointestinal processes, blood vessels, and cellular signaling.
These findings do not establish BPC-157 as an approved treatment for injuries, digestive conditions, muscle recovery, or other medical problems.
Research Areas
Preclinical research has investigated BPC-157 in areas such as:
- Tissue and wound-related processes
- Gastrointestinal mechanisms
- Cellular signaling
- Vascular and blood-flow pathways
- Musculoskeletal research
Human evidence remains insufficient to establish reliable clinical benefits or long-term safety.
Important Safety Information
BPC-157 is not an established dietary supplement or approved general medical treatment.
Because human safety data are limited, potential short- and long-term effects remain uncertain. Product quality may also vary between unregulated research products.
Anyone with a medical condition or taking prescription medication should consult a qualified healthcare professional before considering exposure to an investigational peptide.
